Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$573,327
+$133,677 QoQ
Shares Held
478
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#3,641
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TigerOak Management, L.L.C. holds $6,289,271 across 7 Drug Manufacturers - General names. LLY ranks #3 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,577 | $3,448,150 | |
| 2 | ABBV |
AbbVie Inc.
|
4,032 | $1,014,612 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
478 | $573,327 | |
| 4 | NVS |
Novartis AG
|
3,041 | $476,585 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,794 | $359,029 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,627 | $208,987 | |
| 7 | AMGN |
Amgen Inc
|
576 | $208,581 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $573,327 | 478 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $439,650 | 478 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $513,697 | 478 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $364,714 | 478 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $495,781 | 636 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $558,315 | 676 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $521,872 | 676 | Shares | Sole | 2025-01-30 | |
| No filing history on record for this holder in this stock. | ||||||